Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency
Summary: We characterized Mycobacterium bovis BCG isolates found in lung and brain samples from a previously vaccinated patient with IFNγR1 deficiency. The isolates collected displayed distinct genomic and phenotypic features consistent with host adaptation and associated changes in antibiotic susce...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c389e6b7ad754220ad0f5defb0a60810 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c389e6b7ad754220ad0f5defb0a60810 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c389e6b7ad754220ad0f5defb0a608102021-11-17T14:21:59ZTissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency2150-55942150-560810.1080/21505594.2020.1848108https://doaj.org/article/c389e6b7ad754220ad0f5defb0a608102020-12-01T00:00:00Zhttp://dx.doi.org/10.1080/21505594.2020.1848108https://doaj.org/toc/2150-5594https://doaj.org/toc/2150-5608Summary: We characterized Mycobacterium bovis BCG isolates found in lung and brain samples from a previously vaccinated patient with IFNγR1 deficiency. The isolates collected displayed distinct genomic and phenotypic features consistent with host adaptation and associated changes in antibiotic susceptibility and virulence traits. Background: We report a case of a patient with partial recessive IFNγR1 deficiency who developed disseminated BCG infection after neonatal vaccination (BCG-vaccine). Distinct M. bovis BCG-vaccine derived clinical strains were recovered from the patient’s lungs and brain. Methods: BCG strains were phenotypically (growth, antibiotic susceptibility, lipid) and genetically (whole genome sequencing) characterized. Mycobacteria cell infection models were used to assess apoptosis, necrosis, cytokine release, autophagy, and JAK-STAT signaling. Results: Clinical isolates BCG-brain and BCG-lung showed distinct Rv0667 rpoB mutations conferring high- and low-level rifampin resistance; the latter displayed clofazimine resistance through Rv0678 gene (MarR-like transcriptional regulator) mutations. BCG-brain and BCG-lung showed mutations in fadA2, fadE5, and mymA operon genes, respectively. Lipid profiles revealed reduced levels of PDIM in BCG-brain and BCG-lung and increased TAGs and Mycolic acid components in BCG-lung, compared to parent BCG-vaccine. In vitro infected cells showed that the BCG-lung induced a higher cytokine release, necrosis, and cell-associated bacterial load effect when compared to BCG-brain; conversely, both strains inhibited apoptosis and altered JAK-STAT signaling. Conclusions: During a chronic-disseminated BCG infection, BCG strains can evolve independently at different sites likely due to particular microenvironment features leading to differential antibiotic resistance, virulence traits resulting in dissimilar responses in different host tissues.Cecilia B. KorolShamira J. ShallomKriti AroraHelena I. BoshoffAlexandra F. FreemanAlejandra KingSonia AgrawalSean C. DaughertyTimothy JancelJuraj KabatSundar GanesanMarina N. TorreroElizabeth P. SampaioClifton BarrySteve M HollandHervé TettelinSergio D RosenzweigAdrian M. ZelaznyTaylor & Francis Grouparticletuberculosisbcgantibiotic resistanceimmunodeficiencymendelian susceptibility to mycobacterial diseasesinterferon-γInfectious and parasitic diseasesRC109-216ENVirulence, Vol 11, Iss 1, Pp 1656-1673 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
tuberculosis bcg antibiotic resistance immunodeficiency mendelian susceptibility to mycobacterial diseases interferon-γ Infectious and parasitic diseases RC109-216 |
spellingShingle |
tuberculosis bcg antibiotic resistance immunodeficiency mendelian susceptibility to mycobacterial diseases interferon-γ Infectious and parasitic diseases RC109-216 Cecilia B. Korol Shamira J. Shallom Kriti Arora Helena I. Boshoff Alexandra F. Freeman Alejandra King Sonia Agrawal Sean C. Daugherty Timothy Jancel Juraj Kabat Sundar Ganesan Marina N. Torrero Elizabeth P. Sampaio Clifton Barry Steve M Holland Hervé Tettelin Sergio D Rosenzweig Adrian M. Zelazny Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency |
description |
Summary: We characterized Mycobacterium bovis BCG isolates found in lung and brain samples from a previously vaccinated patient with IFNγR1 deficiency. The isolates collected displayed distinct genomic and phenotypic features consistent with host adaptation and associated changes in antibiotic susceptibility and virulence traits. Background: We report a case of a patient with partial recessive IFNγR1 deficiency who developed disseminated BCG infection after neonatal vaccination (BCG-vaccine). Distinct M. bovis BCG-vaccine derived clinical strains were recovered from the patient’s lungs and brain. Methods: BCG strains were phenotypically (growth, antibiotic susceptibility, lipid) and genetically (whole genome sequencing) characterized. Mycobacteria cell infection models were used to assess apoptosis, necrosis, cytokine release, autophagy, and JAK-STAT signaling. Results: Clinical isolates BCG-brain and BCG-lung showed distinct Rv0667 rpoB mutations conferring high- and low-level rifampin resistance; the latter displayed clofazimine resistance through Rv0678 gene (MarR-like transcriptional regulator) mutations. BCG-brain and BCG-lung showed mutations in fadA2, fadE5, and mymA operon genes, respectively. Lipid profiles revealed reduced levels of PDIM in BCG-brain and BCG-lung and increased TAGs and Mycolic acid components in BCG-lung, compared to parent BCG-vaccine. In vitro infected cells showed that the BCG-lung induced a higher cytokine release, necrosis, and cell-associated bacterial load effect when compared to BCG-brain; conversely, both strains inhibited apoptosis and altered JAK-STAT signaling. Conclusions: During a chronic-disseminated BCG infection, BCG strains can evolve independently at different sites likely due to particular microenvironment features leading to differential antibiotic resistance, virulence traits resulting in dissimilar responses in different host tissues. |
format |
article |
author |
Cecilia B. Korol Shamira J. Shallom Kriti Arora Helena I. Boshoff Alexandra F. Freeman Alejandra King Sonia Agrawal Sean C. Daugherty Timothy Jancel Juraj Kabat Sundar Ganesan Marina N. Torrero Elizabeth P. Sampaio Clifton Barry Steve M Holland Hervé Tettelin Sergio D Rosenzweig Adrian M. Zelazny |
author_facet |
Cecilia B. Korol Shamira J. Shallom Kriti Arora Helena I. Boshoff Alexandra F. Freeman Alejandra King Sonia Agrawal Sean C. Daugherty Timothy Jancel Juraj Kabat Sundar Ganesan Marina N. Torrero Elizabeth P. Sampaio Clifton Barry Steve M Holland Hervé Tettelin Sergio D Rosenzweig Adrian M. Zelazny |
author_sort |
Cecilia B. Korol |
title |
Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency |
title_short |
Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency |
title_full |
Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency |
title_fullStr |
Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency |
title_full_unstemmed |
Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency |
title_sort |
tissue specific diversification, virulence and immune response to mycobacterium bovis bcg in a patient with an ifn-γ r1 deficiency |
publisher |
Taylor & Francis Group |
publishDate |
2020 |
url |
https://doaj.org/article/c389e6b7ad754220ad0f5defb0a60810 |
work_keys_str_mv |
AT ceciliabkorol tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT shamirajshallom tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT kritiarora tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT helenaiboshoff tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT alexandraffreeman tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT alejandraking tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT soniaagrawal tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT seancdaugherty tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT timothyjancel tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT jurajkabat tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT sundarganesan tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT marinantorrero tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT elizabethpsampaio tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT cliftonbarry tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT stevemholland tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT hervetettelin tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT sergiodrosenzweig tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency AT adrianmzelazny tissuespecificdiversificationvirulenceandimmuneresponsetomycobacteriumbovisbcginapatientwithanifngr1deficiency |
_version_ |
1718425443759030272 |